It is time to change US trade policy to foster access to medicines

被引:0
|
作者
Jorge, Maria Fabiana [1 ]
机构
[1] MFJ Int LLC, 1032 29th St, Washington, DC 20007 USA
关键词
Access to medicines; biosimilars; generic drugs; trade agreements; USMCA;
D O I
10.5639/gabij.2020.0901.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
While Americans arc deeply concerned about drug prices, the United States Trade Representative (USTR) continues to negotiate agreements like the United States-Mexico-Canada Agreement (USMCA) that put at risk the sustainability of the generics industry and undermine the development of biosimilars that play a critical role in access to medicines. It is time to restore some balance to LS trade policy.
引用
收藏
页码:24 / 27
页数:4
相关论文
共 50 条